Evidence map›Paper›PMID 26491289›Full record

ArticleInternational journal of nanomedicine2015

Rapid and quantitative detection of C-reactive protein based on quantum dots and immunofiltration assay.

Pengfei Zhang, Yan Bao, Mohamed Shehata Draz, Huiqi Lu, Chang Liu, Huanxing Han

Abstract read
In one paragraph

Article in International journal of nanomedicine, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Pengfei ZhangCenter for Translational Medicine, Changzheng Hospital, Second Military Medical University, Shanghai, People's Republic of China.
Yan BaoCenter for Translational Medicine, Changzheng Hospital, Second Military Medical University, Shanghai, People's Republic of China.
Mohamed Shehata DrazZhejiang-California International Nanosystems Institute, Zhejiang University, Hangzhou, Zhejiang, People's Republic of China ; Faculty of Science, Tanta University, Tanta, Egypt.
Huiqi LuCenter for Translational Medicine, Changzheng Hospital, Second Military Medical University, Shanghai, People's Republic of China.
Chang LiuCenter for Translational Medicine, Changzheng Hospital, Second Military Medical University, Shanghai, People's Republic of China.
Huanxing HanCenter for Translational Medicine, Changzheng Hospital, Second Military Medical University, Shanghai, People's Republic of China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Convenient and rapid immunofiltration assays (IFAs) enable on-site "yes" or "no" determination of disease markers. However, traditional IFAs are commonly qualitative or semi-quantitative and are very limited for the efficient testing of samples in field diagnostics. Here, we overcome these limitations by developing a quantum dots (QDs)-based fluorescent IFA for the quantitative detection of C-reactive proteins (CRP). CRP, the well-known diagnostic marker for acute viral and bacterial infections, was used as a model analyte to demonstrate performance and sensitivity of our developed QDs-based IFA. QDs capped with both polyethylene glycol (PEG) and glutathione were used as fluorescent labels for our IFAs. The presence of the surface PEG layer, which reduced the non-specific protein interactions, in conjunction with the inherent optical properties of QDs, resulted in lower background signal, increased sensitivity, and ability to detect CRP down to 0.79 mg/L with only 5 µL serum sample. In addition, the developed assay is simple, fast and can quantitatively detect CRP with a detection limit up to 200 mg/L. Clinical test results of our QD-based IFA are well correlated with the traditional latex enhance immune-agglutination aggregation. The proposed QD-based fluorescent IFA is very promising, and potentially will be adopted for multiplexed immunoassay and in field point-of-care test.

Indexed as

Quantum DotsC-Reactive ProteinFiltrationGlutathioneHepacivirusHepatitis B, ChronicHepatitis B virusHepatitis CHumansImmunoassayLimit of DetectionPoint-of-Care SystemsPolyethylene GlycolsC-Reactive ProteinGlutathionePolyethylene GlycolsC-reactive proteinsGlutathione capped QDsPEGylationpoint-of-care test

Identifiers

PMID26491289
PMCPMC4598213

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.